Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about BIOVF
Recent news which mentions BIOVF
Merck Virus Treatment Shows 60.4% Effectiveness, Reduces Certain Infections In Infants
October 18, 2024
Tickers
BIOVF
MRK
NEWS
Tags
News
Large Cap
Health Care
From
Benzinga
Apellis Pharmaceuticals' Pegcetacoplan Meets Primary Goal In Late-Stage Study In Patients With Rare Kidney Diseases
August 08, 2024
Tickers
APLS
BIOVF
NEWS
SWOBY
Tags
Market News
why it's moving
BIOVF
From
Benzinga
Pfizer, Sanofi's Respiratory Syncytial Virus Products Faces Insurance And Logistical Hurdles To Protect Infants
October 16, 2023
Tickers
AZN
BIOVF
PFE
SNY
Tags
Biotech
Benzinga
PFE
From
Benzinga
Unanimous Support for AstraZeneca and Sanofi's Nirsevimab: Next Generation RSV Treatment on the Horizon
June 09, 2023
Tickers
AZN
AZNCF
BIOVF
SNY
Tags
AZN
Market News
SNY
From
Benzinga
Apellis Pharma Flunks On Primary, Secondary Endpoints In Amyotrophic Lateral Sclerosis Study
May 25, 2023
Tickers
APLS
BIOVF
Tags
Briefs
News
APLS
From
Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
May 11, 2023
Tickers
ABNB
BIOVF
CTIC
PACW
Tags
CTIC
Stocks To Watch
Small Cap
From
Benzinga
Why Shares of CTI BioPharma Are Soaring Wednesday
May 10, 2023
Tickers
BIOVF
CTIC
Tags
CTIC
Recent Press Releases
Market News
From
Motley Fool
European Swedish Orphan Biovitrum To Acquire CTI BioPharma For $1.7B
May 10, 2023
Tickers
BIOVF
CTIC
Tags
why it's moving
Market News
M&A
From
Benzinga
Selecta, SOBI's Chronic Refractory Gout Program Meets Primary Goal, US Submission Expected Next Year
March 21, 2023
Tickers
BIOVF
SELB
Tags
Market News
SELB
BIOVF
From
Benzinga
Veru Stock Could Retrace Week's 45% Gain As FDA Panel Votes Against COVID-19 Drug
November 10, 2022
Tickers
BIOVF
VERU
Tags
FDA
General
Small Cap
From
Benzinga
Europe Approves AstraZeneca-Sanofi Partnered Antibody To Prevent RSV Infection In Infants
November 04, 2022
Tickers
AZN
AZNCF
BIOVF
SNY
Tags
Briefs
Benzinga
Biotech
From
Benzinga
Sanofi's Hemophilia Candidate Goes Under Priority FDA Review
August 30, 2022
Tickers
BIOVF
SNY
Tags
FDA
General
Market News
From
Benzinga
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After
July 11, 2022
Tickers
BIOVF
CANF
IBB
INVA
Tags
IONS
Small Cap
General
From
Benzinga
SOBI-Sanofi Partnered Hemophilia Therapy Shows Superior Bleed Protection Than Prior Prophylaxis
July 11, 2022
Tickers
BIOVF
SNY
Tags
SNY
News
Briefs
From
Benzinga
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
July 08, 2022
Tickers
ADCT
ANNX
ATHX
BIOVF
Tags
IBB
ATHX
NRIX
From
Benzinga
ADC Therapeutics, Sobi Ink European Licensing Pact For Lymphoma Drug
July 08, 2022
Tickers
ADCT
BIOVF
Tags
ADCT
Biotech
Benzinga
From
Benzinga
Sanofi-SOBI Hemophilia Candidate Aces Late-Stage Study In Pretreated Patients
March 09, 2022
Tickers
BIOVF
SNY
Tags
General
Benzinga
Phase 3 Results
From
Benzinga
Apellis - Sobi's Pegcetacoplan Wins European Approval For Rare Blood Disorder
December 15, 2021
Tickers
APLS
BIOVF
Tags
Market News
Blood Disorders
General
From
Benzinga
AstraZeneca Blocks SOBI's $8B Buyout, Advent Withdraws The Bid - Report
December 03, 2021
Tickers
AZN
AZNCF
BIOVF
Tags
News
Briefs
Benzinga
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.